Graves' disease following successful treatment of severe aplastic anaemia with antilymphocyte globulin

Clinical and Laboratory Haematology

Volumn 21, Issue 1, 1999, Pages 69-70

  Todd, A ^a   Todd, J ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Anti lymphocyte globulin; Aplastic anaemia; Auto immune disorders; Graves' disease; Interleukin 1

Indexed keywords

AUTOANTIBODY; CYCLOSPORIN A; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; IODINE 131; LYMPHOCYTE ANTIBODY; PREDNISOLONE; STEROID; THYROID ANTIBODY;

ADULT; ANEMIA; APLASTIC ANEMIA; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; STEROID THERAPY; THYROID FUNCTION;

ADULT; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; GRAVES DISEASE; HUMANS; MALE;

EID: 0033045049     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.1999.00190.x     Document Type: Article

References (8)

1. Hinterberger-Fischer M., Kier P., Forstinger I. et al. (1994) Coincidence of severe aplastic anaemia with multiple sclerosis or thyroid disorders. Report of 5 cases. Acta Haematologica 92, 136-139.
2. Hsu H.C., Tsai W.H., Chen L.Y. et al. (1996) Production of hematopoietic regulatory cytokines by peripheral blood mononuclear cells in patients with aplastic anaemia. Experimental Haematology 24, 31-36.
3. Nishikawa T., Yamashita S., Namba H. et al. (1993) Interferon gamma inhibition of human thyrotropin receptor gene expression. Journal of Clinical Endocrinology and Metabolism 77, 1084-1089.
4. Paschke R., Kist A., Janicke R. et al. (1993) Lack of intrathyroid tumour necrosis factor alpha in Graves' disease. Journal of Clinical Endocrinology and Metabolism 76, 97-102.
5. Teramura M., Kobayashi S., Iwabe K. et al. (1997) Mechanism of action of antithymocyte globulin in the treatment of aplastic anaemia: in vitro evidence for the presence of immunosuppressive mechanism. British Journal of Haematology 96, 80-84.
6. Wallace W.A., Ramage E.A., Lamb D. et al. (1995) A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis. Clinical and Experimental Immunology 101, 436-441.
7. Yoshikawa N., Mori S., Tokoro T. et al. (1996) IFN-gamma has a protective role against thyroid specific autoantibody production in severe combined immunodeficient (SCID) mice xenografted with Graves' thyroid tissue. Thyroid 6, 437-443.
8. Zomas A., Marsh J.C., Harrison N.K. et al. (1995) Rapid progression of fibrosing alveolitis and thyrotoxicosis after antithymocyte globulin therapy for aplastic anaemia. Annals of Haematology 71, 49-51.